One Day Later

por Van Allen, Eliezer M.
Publicado em 2010

Next-generation sequencing to guide cancer therapy

por Gagan, Jeffrey, Van Allen, Eliezer M.
Publicado no Genome Med (2015)

Precision medicine for advanced prostate cancer

por Mullane, Stephanie A., Van Allen, Eliezer M.
Publicado no Curr Opin Urol (2016)

Delivering on the promise of precision cancer medicine

por Berger, Michael F., Van Allen, Eliezer M.
Publicado no Genome Med (2016)

Tumor Evolution: A Problem of Histocompatibility

por Vokes, Natalie I., Van Allen, Eliezer M.
Publicado no Cell (2017)

Clinical Analysis and Interpretation of Cancer Genome Data

por Van Allen, Eliezer M., Wagle, Nikhil, Levy, Mia A.
Publicado no J Clin Oncol (2013)

Toward Molecularly Driven Precision Medicine in Lung Adenocarcinoma

por Liu, David, Vokes, Natalie I., Van Allen, Eliezer M.
Publicado no Cancer Discov (2017)

Genomic Approaches to Understanding Response and Resistance to Immunotherapy

por Braun, David A., Burke, Kelly P, Van Allen, Eliezer M.
Publicado no Clin Cancer Res (2016)

Genomic correlates of response to immune checkpoint blockade

por Keenan, Tanya E., Burke, Kelly P., Van Allen, Eliezer M.
Publicado no Nat Med (2019)

CoMut: visualizing integrated molecular information with comutation plots

por Crowdis, Jett, He, Meng Xiao, Reardon, Brendan, Van Allen, Eliezer M
Publicado no Bioinformatics (2020)

Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine

por Conway, Jake R., Kofman, Eric, Mo, Shirley S., Elmarakeby, Haitham, Van Allen, Eliezer
Publicado no Genome Med (2018)

Off-Label Use of Rituximab in a Multipayer Insurance System

por Van Allen, Eliezer M., Miyake, Todd, Gunn, Nathan, Behler, Caroline M., Kohlwes, Jeff
Publicado em 2011

Beyond Conventional Immune Checkpoint Inhibition: Renal Cell Carcinoma at the Forefront of Solid Tumor Immunology

por Braun, David A., Bakouny, Ziad, Hirsch, Laure, Flippot, Ronan, Van Allen, Eliezer, Wu, Catherine J., Choueiri, Toni K.
Publicado no Nat Rev Clin Oncol (2021)

Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-invasive Urothelial Bladder Carcinoma

por Liu, David, Plimack, Elizabeth R., Hoffman-Censits, Jean, Garraway, Levi A., Bellmunt, Joaquim, Van Allen, Eliezer, Rosenberg, Jonathan E.
Publicado no JAMA Oncol (2016)

Germline Features Associated with Immune Infiltration in Solid Tumors

por Shahamatdar, Sahar, He, Meng Xiao, Reyna, Matthew A., Gusev, Alexander, AlDubayan, Saud H., Van Allen, Eliezer M., Ramachandran, Sohini
Publicado no Cell Rep (2020)

Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma

por Braun, David A., Ishii, Yuko, Walsh, Alice M., Van Allen, Eliezer M., Wu, Catherine J., Shukla, Sachet A., Choueiri, Toni K.
Publicado no JAMA Oncol (2019)

Natural Language Processing to Ascertain Cancer Outcomes From Medical Oncologist Notes

por Kehl, Kenneth L., Xu, Wenxin, Lepisto, Eva, Elmarakeby, Haitham, Hassett, Michael J., Van Allen, Eliezer M., Johnson, Bruce E., Schrag, Deborah
Publicado no JCO Clin Cancer Inform (2020)

Assessment of Deep Natural Language Processing in Ascertaining Oncologic Outcomes From Radiology Reports

por Kehl, Kenneth L., Elmarakeby, Haitham, Nishino, Mizuki, Van Allen, Eliezer M., Lepisto, Eva M., Hassett, Michael J., Johnson, Bruce E., Schrag, Deborah
Publicado no JAMA Oncol (2019)

Scaling computational genomics to millions of individuals with GPUs

por Taylor-Weiner, Amaro, Aguet, François, Haradhvala, Nicholas J., Gosai, Sager, Anand, Shankara, Kim, Jaegil, Ardlie, Kristin, Van Allen, Eliezer M., Getz, Gad
Publicado no Genome Biol (2019)

Identification of cancer driver genes based on nucleotide context

por Dietlein, Felix, Weghorn, Donate, Taylor-Weiner, Amaro, Richters, André, Reardon, Brendan, Liu, David, Lander, Eric S., Van Allen, Eliezer M., Sunyaev, Shamil R.
Publicado no Nat Genet (2020)